Biomarkers for Liver Cirrhosis: New Research Reveals Key Indicators of Patient Prognosis

Strategic Insights -

Research has shed light on the complex relationship between coronary artery disease (CAD), N-terminal pro-B-type natriuretic peptide (NT-ProBNP), and high-sensitivity cardiac troponin T (hs-cTnT) in patients with liver cirrhosis. A study published in the journal Digestive and Liver Disease found that hs-cTnT 14 ng/L and NT-ProBNP 300 pg/ml are significant indicators of further decompensation and death in patients with liver cirrhosis, rather than CAD. The study, conducted at the General Hospital of Northern Theater Command in Shenyang, People's Republic of China, retrospectively analyzed data from 601 cirrhotic patients admitted between June 2020 and January 2024.

Key Takeaways:

  • Hs-cTnT 14 ng/L and NT-ProBNP 300 pg/ml are significantly associated with higher cumulative incidence of further decompensation and death in patients with liver cirrhosis.
  • Hs-cTnT 14 ng/L is an independent predictor of death in multivariate Cox regression analyses.
  • NT-ProBNP and CAD are not independently associated with further decompensation or death in multivariate competing risk and Cox regression analyses.
  • The study suggests that hs-cTnT and NT-ProBNP should be incorporated in the prognostic model of liver cirrhosis.
  • The research highlights the importance of hs-cTnT and NT-ProBNP as biomarkers for assessing the prognosis of patients with liver cirrhosis.

Statistics:

  • 601 cirrhotic patients were included in the study.
  • The study analyzed data from patients admitted between June 2020 and January 2024.
  • The cumulative incidence of further decompensation and death was higher in patients with hs-cTnT 14 ng/L and NT-ProBNP 300 pg/ml.
  • The hazard ratio for death was 2.041 (p = 0.001) for hs-cTnT 14 ng/L.
  • The study's findings have implications for the development of prognostic models for liver cirrhosis.

Sources:

  • Digestive and Liver Disease
  • General Hospital of Northern Theater Command
  • Yao Xiao et al. "Hs-cTnT and NT-ProBNP, rather than unspecified coronary artery disease, may be associated with further decompensation and death in liver cirrhosis." Digestive and Liver Disease, 2025.
  • NewsRx. Findings from General Hospital of Northern Theater Command Provide New Insights into Liver Cirrhosis (hs-cTnT and NT-ProBNP, rather than unspecified coronary artery disease, may be associated with further decompensation and death in liver ...). Cardiovascular Week. October 20, 2025; p 20.